A more precise risk calculation would benefit diabetes screening programs that have become more common in the United States ...

Immune checkpoint inhibitors may heighten cardiovascular risks by altering immune interactions in atherosclerotic plaques, ...

The pioneering new drug was found to increase average overall survival by almost five months compared to other standard ...

A study uncovers that CD8+ T cells in ME/CFS patients exhibit exhaustion-like states, a condition linked to chronic immune ...

Janux Therapeutics' TRACTr platform shows promise with encouraging early data. Check out what leads me to maintain a “Strong ...

REHOVOT, Israel, Dec. 03, 2024 (GLOBE NEWSWIRE) -- (“Purple Biotech” or the “Company”) (NASDAQ/TASE: PPBT), a clinical-stage ...

Jean C. Pfau, Ph.D. and Kinta Serve provide their perspective on asbestos, the pleural cavity, and autoimmune disease ...

While early and from a small trial, the findings suggest Janux’s method of “masking” T cell engagers could lead to ...

Recent research has unveiled that DNA secreted by tumor cells through extracellular vesicles (EVs) can stimulate an immune response that helps inhibit the spread of tumors to the liver. This ...

Tebentafusp is the first treatment of its kind for uveal melanoma, which develops from cells in the middle layer of the eye, ...